Does the use of targeted agents in advanced gastroesophageal cancer increase complete response? A meta-analysis of 18 randomized controlled trials

PURPOSE: We aimed to investigate whether the use of targeted agents (TAs) in advanced gastroesophageal cancer (GEC) increased the complete response (CR) and to assess the surrogate endpoints for survival in the targeted treatment of GEC by using a meta-analysis of randomized controlled trials (RCTs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yanyang, Shen, Zhen, Sun, Jiancheng, Wang, Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237139/
https://www.ncbi.nlm.nih.gov/pubmed/30519098
http://dx.doi.org/10.2147/CMAR.S174063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237139/
https://www.ncbi.nlm.nih.gov/pubmed/30519098
http://dx.doi.org/10.2147/CMAR.S174063

Ejemplares similares